Viviana Vella

5PUBLICATIONS
27CO-AUTHORS
Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 26, 2026
A Regulatory Element in the Intrinsically Disordered C-Terminal Region of LMTK3 Modulates Its Kinase Domain Interactions and Breast Cancer Phenotypes.

|Oct 16, 2025
Spleen tyrosine kinase (SYK) inhibition suppresses growth of gastrointestinal neuroendocrine tumor cells: a pilot study in two cell lines.

Angeliki Ditsiou, Lara Toffoli, Viviana Vella

|Feb 10, 2024
Decoding the Tumour Microenvironment: Molecular Players, Pathways, and Therapeutic Targets in Cancer Treatment.

Eleonora Malavasi, Manuel Adamo, Elisa Zamprogno

|Jan 08, 2023
The Inhibitory Properties of a Novel, Selective LMTK3 Kinase Inhibitor.

Alessandro Agnarelli, Andrea Lauer Betrán, Athanasios Papakyriakou

|Nov 14, 2020
The structure-function relationship of oncogenic LMTK3.

Angeliki Ditsiou, Chiara Cilibrasi, Nikiana Simigdala

Pageof 1

Frequent Collaborators

4 joint publications

Georgios Giamas

3 joint publications

Angeliki Ditsiou

2 joint publications

Chiara Cilibrasi

2 joint publications

Athanasios Papakyriakou